Literature DB >> 17038538

Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.

Hugo Caldas1, Jason R Fangusaro, Daniel R Boué, Michael P Holloway, Rachel A Altura.   

Abstract

The identification of alternative splice variants of Survivin that possess distinct functions from those originally identified for the main Survivin isoform has greatly increased the complexity of our understanding of the role of Survivin in different cells. Previous functional studies of the Survivin splice variants have been performed almost exclusively in cancer cells. However, Survivin has increasingly been implicated in other normal physiologic and pathophysiologic processes, including angiogenesis. In this study, we dissect the involvement of Survivin DeltaEx3 in angiogenesis. We show by confocal microscopy that a pool of endothelial Survivin DeltaEx3 is localized to membrane ruffles. We also demonstrate that Survivin DeltaEx3 is the Survivin splice variant responsible for modulating angiogenesis in vitro, in tube formation assays, and in vivo, in an in vivo angiogenesis assay. Our data indicate that Survivin DeltaEx3 may regulate angiogenesis via several mechanisms including cell invasion, migration, and Rac1 activation. Our findings identify a novel pathway regulating angiogenesis through Survivin DeltaEx3 and a novel mechanism for Rac1 activation during angiogenesis. In conclusion, our results provide new insights into the regulation of endothelial cell homeostasis and angiogenesis by the Survivin proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17038538      PMCID: PMC1794050          DOI: 10.1182/blood-2006-02-003749

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  40 in total

1.  Identification of a novel nucleolar localization signal and a degradation signal in Survivin-deltaEx3: a potential link between nucleolus and protein degradation.

Authors:  Zhiyin Song; Mian Wu
Journal:  Oncogene       Date:  2005-04-14       Impact factor: 9.867

2.  Essential role for survivin in early brain development.

Authors:  Yuying Jiang; Alain de Bruin; Hugo Caldas; Jason Fangusaro; John Hayes; Edward M Conway; Michael L Robinson; Rachel A Altura
Journal:  J Neurosci       Date:  2005-07-27       Impact factor: 6.167

Review 3.  The GTP-binding protein Rho.

Authors:  A J Ridley
Journal:  Int J Biochem Cell Biol       Date:  1997-11       Impact factor: 5.085

Review 4.  Rho GTPases and the actin cytoskeleton.

Authors:  A Hall
Journal:  Science       Date:  1998-01-23       Impact factor: 47.728

5.  Endothelial intercellular adhesion molecule (ICAM)-2 regulates angiogenesis.

Authors:  Miao-Tzu Huang; Justin C Mason; Graeme M Birdsey; Valerie Amsellem; Nicole Gerwin; Dorian O Haskard; Anne J Ridley; Anna M Randi
Journal:  Blood       Date:  2005-05-26       Impact factor: 22.113

6.  Survivin-directed RNA interference cocktail is a potent suppressor of tumour growth in vivo.

Authors:  H Caldas; M P Holloway; B M Hall; S J Qualman; R A Altura
Journal:  J Med Genet       Date:  2005-05-20       Impact factor: 6.318

7.  Survivin splice variants regulate the balance between proliferation and cell death.

Authors:  Hugo Caldas; Yuying Jiang; Michael P Holloway; Jason Fangusaro; Csaba Mahotka; Edward M Conway; Rachel A Altura
Journal:  Oncogene       Date:  2005-03-17       Impact factor: 9.867

8.  Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway.

Authors:  D Joyce; B Bouzahzah; M Fu; C Albanese; M D'Amico; J Steer; J U Klein; R J Lee; J E Segall; J K Westwick; C J Der; R G Pestell
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

9.  Survivin, Survivin-2B, and Survivin-deItaEx3 expression in medulloblastoma: biologic markers of tumour morphology and clinical outcome.

Authors:  J R Fangusaro; Y Jiang; M P Holloway; H Caldas; V Singh; D R Boué; J Hayes; R A Altura
Journal:  Br J Cancer       Date:  2005-01-31       Impact factor: 7.640

10.  Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies.

Authors:  Hugo Caldas; Laura E Honsey; Rachel A Altura
Journal:  Mol Cancer       Date:  2005-03-02       Impact factor: 27.401

View more
  13 in total

Review 1.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

2.  Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas.

Authors:  Tiffany Doucette; Khatri Latha; Yuhui Yang; Gregory N Fuller; Arvind Rao; Ganesh Rao
Journal:  Neuro Oncol       Date:  2014-03-27       Impact factor: 12.300

Review 3.  Clinico-pathologic relevance of Survivin splice variant expression in cancer.

Authors:  Rosalia de Necochea-Campion; Chien-Shing Chen; Saied Mirshahidi; Frank D Howard; Nathan R Wall
Journal:  Cancer Lett       Date:  2013-06-18       Impact factor: 8.679

4.  Survinin expression in patients with breast cancer during chemotherapy.

Authors:  S R Marsicano; R K Kuniyoshi; F S Gehrke; B C A Alves; L A Azzalis; F L A Fonseca
Journal:  Tumour Biol       Date:  2014-12-24

5.  The tumor gene survivin is highly expressed in adult renal tubular cells: implications for a pathophysiological role in the kidney.

Authors:  Philipp Lechler; Xiaoqing Wu; Wanja Bernhardt; Valentina Campean; Susanne Gastiger; Thomas Hackenbeck; Bernd Klanke; Alexander Weidemann; Christina Warnecke; Kerstin Amann; Dirk Engehausen; Carsten Willam; Kai-Uwe Eckardt; Franz Rödel; Michael Sean Wiesener
Journal:  Am J Pathol       Date:  2007-11       Impact factor: 4.307

Review 6.  Survivin splice variants and their diagnostic significance.

Authors:  Nand K Sah; Chandrabhan Seniya
Journal:  Tumour Biol       Date:  2015-08-06

7.  Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.

Authors:  Yu-Quan Xiong; Hui-Chuan Sun; Xiao-Dong Zhu; Wei Zhang; Peng-Yuan Zhuang; Ju-Bo Zhang; Hua-Xiang Xu; Ling-Qun Kong; Wei-Zhong Wu; Lun-Xiu Qin; Zhao-You Tang
Journal:  J Cancer Res Clin Oncol       Date:  2010-05-21       Impact factor: 4.553

8.  Chk2 phosphorylation of survivin-DeltaEx3 contributes to a DNA damage-sensing checkpoint in cancer.

Authors:  Alessia Lopergolo; Michele Tavecchio; Sofia Lisanti; Jagadish C Ghosh; Takehiko Dohi; Alice Faversani; Valentina Vaira; Silvano Bosari; Nobuhiko Tanigawa; Domenico Delia; Andrew V Kossenkov; Louise C Showe; Dario C Altieri
Journal:  Cancer Res       Date:  2012-05-14       Impact factor: 12.701

9.  Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats.

Authors:  Judit Marsillach; Natàlia Ferré; Jordi Camps; Anna Rull; Raul Beltran; Jorge Joven
Journal:  Mol Cell Biochem       Date:  2007-10-16       Impact factor: 3.396

10.  Performance of survivin mRNA as a biomarker for bladder cancer in the prospective study UroScreen.

Authors:  Georg Johnen; Katarzyna Gawrych; Heike Bontrup; Beate Pesch; Dirk Taeger; Séverine Banek; Matthias Kluckert; Harald Wellhäußer; Friedhelm Eberle; Michael Nasterlack; Gabriele Leng; Arnulf Stenzl; Thomas Brüning
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.